Zeochem AG

Zeochem AG is a Swiss specialty chemicals company with over 200 years of heritage, tracing its origins to a chemical works established in Uetikon on the shores of Lake Zurich in 1818. Today a subsidiary of CPH Chemie + Papier Holding AG (SIX: CPHN), Zeochem is a globally recognized leader in molecular sieves (synthetic zeolites), silica gels, deuterated chemicals, and chromatography packing materials. With approximately 500 employees, estimated annual revenues of ~$200 million, and manufacturing facilities in Switzerland, the United States (Louisville, Kentucky), and China, the company serves customers in over 80 countries across the petrochemical, pharmaceutical, medical device, and specialty gas industries.

Core Business

Zeochem is one of the world's largest independent producers of synthetic zeolite molecular sieves, manufacturing standard pore-size grades (3A, 4A, 5A, 13X) and specialty formulations with tailored SiO₂/Al₂O₃ ratios and cation compositions for applications spanning industrial gas purification, petrochemical dehydration, medical oxygen concentrators, and VOC abatement systems. The company's high-performance LiLSX zeolites are critical components in portable and stationary medical oxygen concentrators — a global market that expanded significantly following the COVID-19 pandemic and continues growing at 8-10% annually. Zeochem's molecular sieves are essential to industrial hydrogen purification via pressure swing adsorption (PSA), natural gas dehydration to pipeline specifications, and the drying of olefin streams (ethylene, propylene) in petrochemical complexes to sub-ppm moisture levels.

The Silica Gel division produces a comprehensive range of indicating, non-indicating, and specialty silica gel products for pharmaceutical packaging, food desiccation, electronics moisture protection, and chromatographic applications. Zeochem's chromatography-grade silicas — with precisely controlled pore sizes (60Å, 100Å, 300Å) and functionalized with C18, C8, amino, cyano, and diol bonded phases — serve analytical, preparative, and process-scale HPLC applications across the global pharmaceutical and biotechnology industries. The company's Deuterated Chemicals division is a leading global supplier of deuterated NMR solvents (CDCl₃, DMSO-d₆, D₂O, and others) and labeled compounds essential for pharmaceutical research, metabolic studies, and mechanistic chemistry, manufactured to >99.8 atom % D enrichment with rigorous quality certification. Additional product lines include lithium-based adsorbents, zeolite moisture scavengers for polyurethane systems, and custom catalyst supports for fine chemical synthesis.

Global Presence

Zeochem operates manufacturing facilities on three continents, with the headquarters and primary R&D center in Zurich/Uetikon, Switzerland — the site of the original 1818 chemical works. The Swiss facility focuses on high-value deuterated chemicals, chromatography media, and specialty zeolite production, serving European and global pharmaceutical and research customers. The Louisville, Kentucky (USA) facility, established in the 1970s, is the company's largest molecular sieve production site, supplying the North American petrochemical, industrial gas, and medical device markets with particular strength in oxygen concentrator zeolites. The China manufacturing base — one of the earlier Western molecular sieve investments in the country — serves the rapidly growing Asian petrochemical, electronics, and industrial gas markets while providing cost-competitive production for global export. The company maintains sales offices and technical support teams across Europe, North America, Asia-Pacific, and the Middle East, serving over 80 countries through a combination of direct sales and a network of specialized chemical distributors.

Key Strengths

Zeochem's competitive advantage is rooted in over two centuries of Swiss chemical manufacturing heritage combined with deep, defensible expertise in zeolite synthesis, silica surface chemistry, and isotopic labeling — three technically demanding disciplines with high barriers to entry. The company's independent status (not vertically integrated into a larger petrochemical or catalyst conglomerate) allows it to serve as a trusted second-source and specialty supplier to customers who value supply chain diversification away from dominant catalyst producers. This position has become increasingly valuable as geopolitical tensions and supply chain disruptions drive industrial customers to seek qualified alternative suppliers for critical functional materials. The deuterated chemicals business benefits from extraordinary barriers to entry — heavy water production infrastructure, multi-stage isotopic enrichment processes, and rigorous quality certification requirements that combine to create a market structure where only 3-4 companies globally can supply research-grade deuterated solvents at commercial scale. The chromatography media business similarly benefits from the pharmaceutical industry's extreme quality requirements and regulatory validation costs, which create high switching costs and sticky customer relationships. VerityRank Score of 76/100.

Data Sources

Key data points verified against: CPH Chemie + Papier Holding AG Annual Report 2024 (SIX Swiss Exchange filing); Zeochem AG corporate website and product technical datasheets; third-party market analysis from MarketsandMarkets (Molecular Sieves Market Report 2025), Grand View Research (Silica Gel Market Analysis), and Mordor Intelligence (Deuterated Solvents Market); U.S. FDA Drug Master File listings; company press releases and trade publication references.